177Lu-PSMA-I ＆T PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer

Condition:   Metastatic Castration-resistant Prostate Cancer Intervention:   Drug: 177 Lu-PSMA-I&T Sponsor:   Nanjing First Hospital, Nanjing Medical University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials